Glycosidase inhibitory flavonoids from Sophora flavescens.

The methanol extract of Sophora flavescens showed a potent glycosidase inhibitory activity. Active components were identified as well-known flavonoid antioxidants: kushenol A (1), (-)-kurarinone (2), sophoraflavanone G (3), 2'-methoxykurarinone (4), kurarinol (5), 8-prenylkaempferol (6), isoxanthohumol (7), kuraridin (8) and maackian (9). All flavonoids were effective inhibitors of alpha-glucosidase and beta-amylase. Interestingly, lavandulylated flavanones 1-5 had strong alpha-glucosidase inhibitory activities, with IC(50) values of 45 microM, 68 microM, 37 microM, 155 microM and 179 microM, respectively. Kushenol A (1) which does not bear a 4'-hydroxy group showed selective alpha-glucosidase inhibitory activity. Lavandulylated chalcone, kuraridine (8), exhibited IC(50) value of 57 microM against beta-glucosidase, which is the first report of a chalcone displaying glycosidase inhibition. Results showed that 8-lavandulyl group in B-ring was a key factor of the glycosidase inhibitory activities. The inhibition pattern was noncompetitive for alpha-glucosidase, whereas mixed inhibition was observed for beta-amylase.

[1]  D. Barron,et al.  Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study. , 2005, Journal of medicinal chemistry.

[2]  T. Okamoto,et al.  Biological properties of D- and L-1-deoxyazasugars. , 2005, Journal of medicinal chemistry.

[3]  C. Lugnier,et al.  Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin. , 2005, Planta medica.

[4]  B. Shukitt-Hale,et al.  Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. , 2004, Free radical biology & medicine.

[5]  Hyun Pyo Kim,et al.  Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. , 2003, Biological & pharmaceutical bulletin.

[6]  Jeong Ah Kim,et al.  Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity. , 2003, Planta medica.

[7]  Yuguo Zheng,et al.  Properties and production of valienamine and its related analogues. , 2003, Chemical reviews.

[8]  P. Vogel,et al.  Synthesis of [(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-5-methylfuran-4-carboxylic acid derivatives: new leads as selective beta-galactosidase inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[9]  Raymond A. Dwek,et al.  Targeting glycosylation as a therapeutic approach , 2002, Nature Reviews Drug Discovery.

[10]  H. W. Chang,et al.  Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. , 2001, Biochemical pharmacology.

[11]  Sang-Han Lee,et al.  Genistein, a soy isoflavone, is a potent α‐glucosidase inhibitor , 2001 .

[12]  N. Terahara,et al.  α-Glucosidase Inhibitory Action of Natural Acylated Anthocyanins. 2. α-Glucosidase Inhibition by Isolated Acylated Anthocyanins , 2001 .

[13]  G. Dacremont,et al.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. , 2000, American journal of human genetics.

[14]  T. Miyamoto,et al.  Cytotoxic lavandulyl flavanones from Sophora flavescens. , 2000, Journal of natural products.

[15]  Jong-Sang Kim,et al.  Inhibition of Alpha-glucosidase and Amylase by Luteolin, a Flavonoid , 2000, Bioscience, biotechnology, and biochemistry.

[16]  S. Antus,et al.  Absolute configuration and total synthesis of (−)-cabenegrin A-I , 1999 .

[17]  C. Scaccini,et al.  Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation. , 1999, Journal of agricultural and food chemistry.

[18]  A. Vasella,et al.  Recent Insights into Inhibition, Structure, and Mechanism of Configuration-Retaining Glycosidases. , 1999, Angewandte Chemie.

[19]  A. Herscovics.  Processing glycosidases of Saccharomyces cerevisiae. , 1999, Biochimica et biophysica acta.

[20]  Nicole Zitzmann,et al.  α‐Glucosidase inhibitors as potential broad based anti‐viral agents , 1998, FEBS letters.

[21]  P. Elwood,et al.  Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  B. Halliwell,et al.  Antioxidants in human health and disease. , 1996, Annual review of nutrition.

[23]  S. Withers,et al.  Mechanism-based inhibition of yeast alpha-glucosidase and human pancreatic alpha-amylase by a new class of inhibitors. 2-Deoxy-2,2-difluoro-alpha-glycosides. , 1995, The Journal of biological chemistry.

[24]  C. Danzin,et al.  New Potent α-Glucohydrolase Inhibitor MDL 73945 With Long Duration of Action in Rats , 1991, Diabetes.

[25]  J. Dennis,et al.  Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. , 1991, Cancer research.

[26]  K. Matsumoto,et al.  Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. , 1986, Cancer research.